Molecular Insight Pharmaceuticals realigns to cut costs

01/7/2010 | MarketWire

Molecular Insight Pharmaceuticals, a developer of targeted drugs and imaging radiopharmaceuticals, has announced its plan to eliminate nine positions in order to cut costs and further support its oncology pipeline. The company expects to save about $1 million annually as a result of the move.

View Full Article in:

MarketWire

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC